Global Gonorrhea Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1661

Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects. 
The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.
One of the major drivers for this market is Rising prevalence of disease. The rising prevalence of gonorrhea is a major health concern globally. The disease follows chlamydial infection as the second most common STD in the US. The rising prevalence rate of gonorrhea is due to several factors such as growing awareness, increased healthcare access, availability of diagnostic tests, resistance patterns, reporting practices, and the financial constraints that limit the abilities of public healthcare officials to check the disease pattern precisely.
In 2018, the global Gonorrhea Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gonorrhea Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gonorrhea Therapeutics development in United States, Europe and China.

The key players covered in this study
Bharat Pharmaceuticals
GlaxoSmithKline
Merck
Pfizer
Alopexx Pharmaceuticals
AstraZeneca
Debiopharm Group
Melinta Therapeutics

Market segment by Type, the product can be split into
Monotherapy
Dual Therapy

Market segment by Application, split into
Clinics
Hospitals
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gonorrhea Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gonorrhea Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gonorrhea Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Dual Therapy
1.5 Market by Application
1.5.1 Global Gonorrhea Therapeutics Market Share by Application (2014-2025)
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gonorrhea Therapeutics Market Size
2.2 Gonorrhea Therapeutics Growth Trends by Regions
2.2.1 Gonorrhea Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gonorrhea Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gonorrhea Therapeutics Market Size by Manufacturers
3.1.1 Global Gonorrhea Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gonorrhea Therapeutics Key Players Head office and Area Served
3.3 Key Players Gonorrhea Therapeutics Product/Solution/Service
3.4 Date of Enter into Gonorrhea Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gonorrhea Therapeutics Market Size by Type (2014-2019)
4.2 Global Gonorrhea Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Gonorrhea Therapeutics Market Size (2014-2019)
5.2 Gonorrhea Therapeutics Key Players in United States
5.3 United States Gonorrhea Therapeutics Market Size by Type
5.4 United States Gonorrhea Therapeutics Market Size by Application

6 Europe
6.1 Europe Gonorrhea Therapeutics Market Size (2014-2019)
6.2 Gonorrhea Therapeutics Key Players in Europe
6.3 Europe Gonorrhea Therapeutics Market Size by Type
6.4 Europe Gonorrhea Therapeutics Market Size by Application

7 China
7.1 China Gonorrhea Therapeutics Market Size (2014-2019)
7.2 Gonorrhea Therapeutics Key Players in China
7.3 China Gonorrhea Therapeutics Market Size by Type
7.4 China Gonorrhea Therapeutics Market Size by Application

8 Japan
8.1 Japan Gonorrhea Therapeutics Market Size (2014-2019)
8.2 Gonorrhea Therapeutics Key Players in Japan
8.3 Japan Gonorrhea Therapeutics Market Size by Type
8.4 Japan Gonorrhea Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gonorrhea Therapeutics Market Size (2014-2019)
9.2 Gonorrhea Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gonorrhea Therapeutics Market Size by Type
9.4 Southeast Asia Gonorrhea Therapeutics Market Size by Application

10 India
10.1 India Gonorrhea Therapeutics Market Size (2014-2019)
10.2 Gonorrhea Therapeutics Key Players in India
10.3 India Gonorrhea Therapeutics Market Size by Type
10.4 India Gonorrhea Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Gonorrhea Therapeutics Market Size (2014-2019)
11.2 Gonorrhea Therapeutics Key Players in Central & South America
11.3 Central & South America Gonorrhea Therapeutics Market Size by Type
11.4 Central & South America Gonorrhea Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bharat Pharmaceuticals
12.1.1 Bharat Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gonorrhea Therapeutics Introduction
12.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.1.5 Bharat Pharmaceuticals Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gonorrhea Therapeutics Introduction
12.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gonorrhea Therapeutics Introduction
12.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gonorrhea Therapeutics Introduction
12.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Alopexx Pharmaceuticals
12.5.1 Alopexx Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gonorrhea Therapeutics Introduction
12.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.5.5 Alopexx Pharmaceuticals Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gonorrhea Therapeutics Introduction
12.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Debiopharm Group
12.7.1 Debiopharm Group Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gonorrhea Therapeutics Introduction
12.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.7.5 Debiopharm Group Recent Development
12.8 Melinta Therapeutics
12.8.1 Melinta Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gonorrhea Therapeutics Introduction
12.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2014-2019)
12.8.5 Melinta Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details